CDKN2A and neoplasm: It is worth noting that silent mutations were excluded from our analysis, implying that the tumor stratifications based on the genotypes of TP53 and CDKN2A genes could be potentially related to the status, i.e. normal or disrupted (altered), of p53 and p16 (or p14ARF) proteins.